Closure of Patent Ductus Arteriosus in Children, Small Infants, and Premature Babies with Amplatzer Duct Occluder II Additional Sizes: Multicenter Study

dc.authoridKARAKURT, CEMŞIT/0000-0002-9246-8107
dc.authoridBaspinar, Osman/0000-0002-9307-0344
dc.authoridOzbarlas, Nazan/0000-0002-3450-5221
dc.authorwosidKARAKURT, CEMŞIT/ABE-2330-2020
dc.authorwosidBaspinar, Osman/ABB-3449-2021
dc.contributor.authorSungur, Metin
dc.contributor.authorKarakurt, Cemsit
dc.contributor.authorOzbarlas, Nazan
dc.contributor.authorBaspinar, Osman
dc.date.accessioned2024-08-04T20:37:43Z
dc.date.available2024-08-04T20:37:43Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjectivesTo evaluate safety and efficacy of closure of patent ductus arteriosus (PDA) with Amplatzer duct occluder II Additional Sizes (ADO II AS) and to report early and midterm results of the device in children and very young symptomatic infants. MethodsRetrospective analysis of angiographic data of 60 children from four pediatric cardiology centers. ResultsThe median patient age and weight were 6.5 (0.5-168) months and 6.8 (1.19-57) kg, respectively. In the study, 26 children had a body weight of 6 kg. Of these 26 children, 9 had a body weight of 3 kg. The median narrowest diameter of PDA was 2 (1.2-4) mm. Ductal anatomy was Type A in 29, Type B in 2, Type C in 11, Type D in 1, and Type E in 16 patients, and a residual PDA after surgery in 1 patient. Closure with ADO II AS was achieved in 58 (96.6%) of 60 attempted cases. In two infants, the device was not released because of significant residual shunt. ADO II was used in one, and the other was sent to surgery. Complete closure was observed in all ADO II AS deployed children by the next day on echocardiography. Median follow-up was 12 (1-18) months. Neither death nor any major complications occurred. ConclusionsOur study shows that closure of medium and small sized PDA by using ADO II AS device is effective and safe in children. The use of the device will expand the field of application of PDA closure in small infants. (c) 2013 Wiley Periodicals, Inc.en_US
dc.identifier.doi10.1002/ccd.24905
dc.identifier.endpage252en_US
dc.identifier.issn1522-1946
dc.identifier.issn1522-726X
dc.identifier.issue2en_US
dc.identifier.pmid23460349en_US
dc.identifier.scopus2-s2.0-84880602725en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage245en_US
dc.identifier.urihttps://doi.org/10.1002/ccd.24905
dc.identifier.urihttps://hdl.handle.net/11616/96144
dc.identifier.volume82en_US
dc.identifier.wosWOS:000329217100024en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofCatheterization and Cardiovascular Interventionsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectpatent ductus arteriosusen_US
dc.subjectduct occluderen_US
dc.subjectchildrenen_US
dc.subjectpremature babyen_US
dc.subjectpediatric interventionsen_US
dc.titleClosure of Patent Ductus Arteriosus in Children, Small Infants, and Premature Babies with Amplatzer Duct Occluder II Additional Sizes: Multicenter Studyen_US
dc.typeArticleen_US

Dosyalar